Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.
Siddharth M PatelMichael G PalazzoloSabina A MurphyElliot M AntmanEugene BraunwaldHans-Joachim LanzGregory Y H LipRobert P GiuglianoChristian T RuffPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
Atrial fibrillation Better Care pathway-concordant care is associated with reductions across multiple CV endpoints and all-cause mortality, with benefit in edoxaban- and warfarin-treated patients and across patient subgroups. Increasing implementation of ABC-concordant care may improve clinical outcomes of patients with AF irrespective of anticoagulant.
Keyphrases
- atrial fibrillation
- healthcare
- quality improvement
- palliative care
- oral anticoagulants
- catheter ablation
- left atrial
- venous thromboembolism
- left atrial appendage
- direct oral anticoagulants
- end stage renal disease
- heart failure
- pain management
- chronic kidney disease
- newly diagnosed
- ejection fraction
- affordable care act
- randomized controlled trial
- primary care
- percutaneous coronary intervention
- acute coronary syndrome
- study protocol
- peritoneal dialysis
- phase iii